Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion Pharmaceuticals announced positive Phase 1b/2 results from its ongoing TUPELO trial ...
SEOUL – “I heard about it only this morning,” Park Hae-soo says. “They briefed me right before this interview. It still hasn’t quite sunk in.” Seated in a Samcheong-dong cafe recently, the South ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback